A Clinical Investigation of the Discovery™ Elbow System
This study is enrolling participants by invitation only.
Sponsor:
Biomet Orthopedics, LLC
Information provided by (Responsible Party):
Biomet, Inc. ( Biomet Orthopedics, LLC )
ClinicalTrials.gov Identifier:
NCT00698867
First received: June 13, 2008
Last updated: January 31, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of function will determine long-term clinical outcome while durability will be measured by the absence of revisions.
| Condition |
|---|
|
Osteoarthritis Rheumatoid Arthritis Avascular Necrosis Humeral Fractures |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | A Prospective, Non-controlled, Clinical Investigation of the Discovery™ Elbow System |
Resource links provided by NLM:
Further study details as provided by Biomet, Inc.:
Primary Outcome Measures:
- ASES Assessment [ Time Frame: 5 years ] [ Designated as safety issue: No ]Evaluation of pain and function compiled by the Patient ASES scores Evaluation of signs,stability, strength and range of motion from the Physician ASES scores
Secondary Outcome Measures:
- Incidence of revision or removals [ Time Frame: Any time ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 120 |
| Study Start Date: | June 2002 |
| Estimated Study Completion Date: | June 2015 |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Discovery™ Elbow
Discovery™ Elbow minimally constrained
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients in need of relief from painful or disabling Joint Disease in need of total elbow replacment.
Criteria
Inclusion Criteria:
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- Inflammatory arthritis
- Revision where other devices or treatments have failed
- Correction of functional deformity
- Treatment of acute fractures or non-union about the elbow
Patient Selection factors to be considered include:
- Need to obtain pain relief and improve function.
- Ability and willingness to follow instructions including control of weight and activity levels.
- Patients who are able and willing to return for follow-up evaluations.
- Patients with a good nutritional state.
- Patients with full skeletal maturity.
- Patients of all races and gender.
- Patients who are able to follow care instructions.
Exclusion Criteria:
- Patients less than 18 years.
- Patients with marked bone loss which would preclude proper fixation of the prosthesis.
- Metabolic disorders, which may impair bone formation.
- Patients who are pregnant.
- Patients with an active or suspected infection in or around the elbow or distant foci of infections, which may spread to the implant site.
- Patients with a highly communicable disease or diseases that may limit follow-up (e.g. immuno-compromised conditions, hepatitis, active tuberculosis, neoplastic disease, etc.).
- Patients unwilling or unable to comply with a rehabilitation program for elbow replacement or who indicate difficulty or inability to return for follow-up visits prescribed by the study protocol.
- Patients who qualify for inclusion in the study, but refuse consent to participate in the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00698867
Locations
| United States, Florida | |
| Florida Orthopedic Institute | |
| Tampa, Florida, United States, 33637 | |
| United States, Indiana | |
| The Indiana Hand Center | |
| Indianapolis, Indiana, United States, 46260 | |
| United States, Massachusetts | |
| Massachusetts General Hospital | |
| Boston, Massachusetts, United States, 02114 | |
| United States, Tennessee | |
| Vanderbilt Hand Center | |
| Nashville, Tennessee, United States, 37232 | |
Sponsors and Collaborators
Biomet Orthopedics, LLC
Investigators
| Study Director: | Russell Schenck, PhD | Director, Clinical Research, Biomet Orthopedics, LLC |
More Information
No publications provided
| Responsible Party: | Biomet, Inc. ( Biomet Orthopedics, LLC ) |
| ClinicalTrials.gov Identifier: | NCT00698867 History of Changes |
| Obsolete Identifiers: | NCT00515515 |
| Other Study ID Numbers: | Biomet 12381-8 |
| Study First Received: | June 13, 2008 |
| Last Updated: | January 31, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Biomet, Inc.:
|
Total Elbow Arthroplasty Total Elbow Replacement Osteoarthritis Elbow arthritis |
Additional relevant MeSH terms:
|
Arthritis Arthritis, Rheumatoid Humeral Fractures Necrosis Osteonecrosis Osteoarthritis Joint Diseases Musculoskeletal Diseases Rheumatic Diseases |
Connective Tissue Diseases Autoimmune Diseases Immune System Diseases Arm Injuries Wounds and Injuries Fractures, Bone Pathologic Processes Bone Diseases |
ClinicalTrials.gov processed this record on May 16, 2013